Antibody signatures reflect different disease pathologies in patients with schistosomiasis due to schistosoma japonicum

Journal of Infectious Diseases

Volumn 213, Issue 1, 2016, Pages 122-130

  Driguez, Patrick ^a   Li, Yuesheng ^a,d   Gaze, Soraya ^b,e   Pearson, Mark S ^b   Nakajima, Rie ^f   Trieu, Angela ^a   Doolan, Denise L ^a   Felgner, Philip L ^f   Hou, Xunya ^d   Cardoso, Fernanda C ^a,c   Jasinskas, Algis ^f   Gobert, Geoffrey N ^a   Loukas, Alex ^b   Mcmanus, Donald P ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d HUNAN INSTITUTE OF PARASITIC DISEASES   (China)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

schistosomiasis; antibody; human disease; Schistosoma japonicum; protein microarray; immunology

Indexed keywords

CARRIER PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIGEN; TETRASPANIN; HELMINTH ANTIBODY; HELMINTH PROTEIN;

ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FECES ANALYSIS; HUMAN; HUMORAL IMMUNITY; INFECTION RESISTANCE; PRIORITY JOURNAL; PROTEIN MICROARRAY; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; ANIMAL; BLOOD; CLASSIFICATION; CLUSTER ANALYSIS; COHORT ANALYSIS; IMMUNOLOGY; SCHISTOSOMIASIS;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CLUSTER ANALYSIS; COHORT STUDIES; HELMINTH PROTEINS; HUMANS; PROTEIN ARRAY ANALYSIS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

EID: 84962018786     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv356     Document Type: Article

References (48)

1. Hotez PJ, Alvarado M, Basáñez M-G, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014; 8: e2865
2. McManus DP, Gray DJ, Li Y, et al. Schistosomiasis in the People s Republic of China: the era of the Three Gorges Dam. Clin Microbiol Rev 2010; 23: 442-66
3. Li YL, Herter U, Ruppel A. Acute, chronic and late-stage infections with Schistosoma japonicum: reactivity of patient sera in indirect immunofluorescence tests. Ann Trop Med Parasitol 2004; 98: 49-57
4. Gryseels B. Schistosomiasis. Infect Dis Clin North Am 2012; 26: 383-97
5. Ross AG, Sleigh AC, Li Y, et al. Schistosomiasis in the People s Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 2001; 14: 270-95
6. Olveda R. Disease in schistosomiasis Japonica. In: Mahmoud AA, ed. Schistosomiasis. London: Imerial College Press, 2001: 361-89
7. Li Y, Chen D, Ross AG, et al. Severe hepatosplenic schistosomiasis: clinicopathologic study of 102 cases undergoing splenectomy. Hum Pathol 2011; 42: 111-9
8. de Jesus AR, Silva A, Santana LB, et al. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis 2002; 185: 98-105
9. Oliveira RR, Figueiredo JP, Cardoso LS, et al. Factors associated with resistance to Schistosoma mansoni infection in an endemic Area of Bahia, Brazil. Am J Trop Med Hyg 2012; 86: 296-305
10. Caldas IR, Campi-Azevedo AC, Oliveira LF, Silveira AM, Oliveira RC, Gazzinelli G. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop 2008; 108: 109-17
11. Li Y, Sleigh AC, Ross AG, et al. Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigens. Trans R Soc Trop Med Hyg 2001; 95: 441-8
12. Mutapi F, Burchmore R, Mduluza T, Midzi N, Turner CM, Maizels RM. Agerelated and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis 2008; 198: 167-75
13. Li Y, Yu DB, Li YS, et al. Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China. Trans R Soc Trop Med Hyg 2002; 96: 210-5
14. Li Y, Zeng Q, Ellis MK, Xiong T, Balen J, McManus DP. CD4+ T-cell counts, CD4+/CD8+ T-cell count ratios, and antibody levels in migrant fishermen infected with Schistosoma japonicum in the Dongting Lake, China. Am J Trop Med Hyg 2006; 75: 910-3
15. Li YS, Ross AG, Sleigh AC, et al. Antibody isotype responses, infection and reinfection for Schistosoma japonicum in a marshland area of China. Acta Trop 1999; 73: 79-92
16. Zhong ZR, Zhou HB, Li XY, et al. Serological proteome-oriented screening and application of antigens for the diagnosis of Schistosomiasis japonica. Acta Trop 2010; 116: 1-8
17. Boamah D, Kikuchi M, Huy NT, et al. Immunoproteomics identification of major IgE and IgG4 reactive Schistosoma japonicum adult worm antigens using chronically infected human Plasma. Trop Med Health 2012; 40: 89-102
18. Xu X, Zhang Y, Lin D, et al. Serodiagnosis of Schistosoma japonicum infection: genome-wide identification of a protein marker, and assessment of its diagnostic validity in a field study in China. Lancet Infect Dis 2014; 14: 489-97
19. Gaze S, Driguez P, Pearson MS, et al. An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog 2014; 10: e1004033
20. Ellis MK, Li Y, Hou X, Chen H, McManus DP. sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica. Int J Parasitol 2008; 38: 717-23
21. Li YS, He YK, Zeng QR, McManus DP. Epidemiological and morbidity assessment of Schistosoma japonicum infection in a migrant fisherman community, the Dongting Lake region, China. Trans R Soc Trop Med Hyg 2003; 97: 177-81
22. Zhu HQ, Xu J, Zhu R, et al. Comparison of the miracidium hatching test and modified Kato-Katz method for detecting Schistosoma japonicum in low prevalence areas of China. Southeast Asian J Trop Med Public Health 2014; 45: 20-5
23. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP. Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 2010; 3: 4
24. Driguez P, Doolan D, Molina D, et al. Protein Microarrays for Parasite Antigen Discovery. In: Peacock C, ed. Parasite Genomics Protocols. Vol. 1201. New York: Springer, 2015: 221-33
25. Davies DH, Liang X, Hernandez JE, et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 2005; 102: 547-52
26. Li Y, Ross AG, Li Y, He YK, Luo XS, McManus DP. Serological diagnosis of Schistosoma japonicum infections in China. Trans R Soc Trop Med Hyg 1997; 91: 19-21
27. Ishida MMI, Rubinsky-Elefant G, Ferreira AW, Hoshino-Shimizu S, Vaz AJ. Helminth antigens (Taenia solium, Taenia crassiceps, Toxocara canis, Schistosoma mansoni and Echinococcus granulosus) and cross-reactivities in human infections and immunized animals. Acta Trop 2003; 89: 73-84
28. Karmakar S, Zhang W, Ahmad G, et al. Use of an Sm-p80-Based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. J Infect Dis 2014; 209: 1929-40
29. Tran MH, Pearson MS, Bethony JM, et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 2006; 12: 835-40
30. Koster B, Hall MRT, Strand M. Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23. Exp Parasitol 1993; 77: 282-94
31. Latysheva N, Muratov G, Rajesh S, et al. Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol Cell Biol 2006; 26: 7707-18
32. Figueiredo BC, Assis NRG, Morais SB, et al. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection. PLoS Negl Trop Dis 2014; 8: e3107
33. Wilson RA. Proteomics at the schistosome-mammalian host interface: any prospects for diagnostics or vaccines? Parasitology 2012; 139: 1-17
34. Glanfield A, McManus DP, Smyth DJ, et al. A cytochrome b561 with ferric reductase activity from the parasitic blood fluke, Schistosoma japonicum. PLoS Negl Trop Dis 2010; 4: e884
35. Wu W, Cai P, Chen Q, Wang H. Identification of novel antigens within the Schistosoma japonicum tetraspanin family based on molecular characterization. Acta Trop 2011; 117: 216-24
36. Rubinstein E. The complexity of tetraspanins. Biochem Soc Trans 2011; 39: 501-5
37. Curti E, Kwityn C, Zhan B, et al. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: A vaccine candidate for human intestinal schistosomiasis. Hum Vaccin Immunotherapeutics 2013; 9: 2342-50
38. Cardoso FC, Pacifico RN, Mortara RA, Oliveira SC. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin Exp Immunol 2006; 144: 382-91
39. Cardoso FC, Macedo GC, Gava E, et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2008; 2: e308
40. Santiago ML, Hafalla JC, Kurtis JD, et al. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides. Int Arch Allergy Immunol 1998; 117: 94-104
41. Fitzsimmons CM, Jones FM, Pinot de Moira A, et al. Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis? Infect Immun 2012; 80: 4264-80
42. Mitchell KM, Mutapi F, Savill NJ, Woolhouse MEJ. Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci 2012; 109: 13347-52
43. Galvani AP. Age-dependent epidemiological patterns and strain diversity in helminth parasites. J Parasitol 2005; 91: 24-30
44. Cai P, Bu L, Wang J, Wang Z, Zhong X, Wang H. Molecular characterization of Schistosoma japonicum tegument protein tetraspanin-2: sequence variation and possible implications for immune evasion. Biochem Biophys Res Commun 2008; 372: 197-202
45. Xu X, Sun J, Zhang J, et al. Having a pair: the key to immune evasion for the diploid pathogen Schistosoma japonicum. Sci Rep 2012; 2: 346
46. Eberl M, Langermans JAM, Vervenne RA, et al. Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive? J Infect Dis 2001; 183: 1238-47
47. van Diepen A, Smit CH, van Egmond L, et al. Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray. PLoS Negl Trop Dis 2012; 6: e1922
48. Kariuki TM, Farah IO, Wilson RA, Coulson PS. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes. Parasite Immunol 2008; 30: 554-62